Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method

• Ngā kaituhi matua: Thomas Müller (Author), Carolin Tasser (Author), Michael Tesar (Author), Ivica Fucek (Author), Ute Schniegler-Mattox (Author), Joachim Koch (Author), Kristina Ellwanger (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

ABSTRACTA challenge when developing therapeutic antibodies is the identification of candidates with favorable pharmacokinetics (PK) early in development. A key determinant of immunoglobulin (IgG) serum half‑life in vivo is the efficiency of pH-dependent binding to the neonatal Fc receptor (FcRn). Nu...